Investors Are Piling Into Nvidia Stock. But Nvidia Is Investing in 5 Other AI Stocks.
Over any meaningful time span, Nvidia (NASDAQ: NVDA) has been a blockbuster investment. It's up almost 1,800% over the last ...
Sunday, November 24, 2024
Tag: investing
EY: Health Executives Are Implementing Digital Health, But Aren’t Seeing ROI Yet
Following the Covid-19 pandemic, there has been a boom in the digital health space. But health executives aren’t seeing the ...
Elation Health’s New Integration Brings Drug Pricing Transparency to the Point of Care for PCPs
For U.S. consumers, the pharmacy can sometimes be a bit of a scary place. Many Americans have been hit with ...
Why Communicating Data Results is Critical to Long-Term BioPharma Success
Early-stage biotech companies experience many important inflection points from funding milestones to regulatory updates to an IPO. However, data readouts ...
AI Biotech Exscientia Fires CEO Hopkins for Relationships With Two Employees
Exscientia founder and CEO Andrew Hopkins is out of a job after an investigation found the CEO engaged in relationships ...
“The Name May Be ‘Neue’ but Their Problems are Old”: Will Bright Health’s Rebrand Save It?
When insurtech Bright Health Group first emerged back in 2015, it had bold goals of disrupting the insurance industry by ...
Nvidia is reportedly investing $30 billion in new custom chip unit
In context: The booming AI sector has propelled Nvidia's financials to new heights, as its AI acceleration GPUs have become ...
Everly Health Partners With National Kidney Foundation, Expands Kidney Health Testing Suite
Everly Health is teaming up with the National Kidney Foundation to improve education around chronic kidney disease, the company announced ...
MedCity News Launches Debunked, A Show Where We Slaughter Myths, Bad Practices and Sacred Cows in Healthcare
Over the years, I have experienced many things as a healthcare consumer that have made me want to rip my ...
Eli Lilly Fatty Liver Drug Posts Promising Early Data, But Field Is Still Competitive
Eli Lilly metabolic disorder medication tirzepatide, already approved in type 2 diabetes and weight management, now has early clinical data ...